Shigemi Hitomi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shigemi Hitomi has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
Satoshi Kimura
Department of Infection Control and Prevention, University of Tokyo Hospital, Tokyo, Japan
3 shared publicationsYuji Morisawa
Department of Infection Control and Prevention, University of Tokyo Hospital, Tokyo, Japan
2 shared publications- Atsushi Yoshida
Department of Infection Control and Prevention, University of Tokyo Hospital, Tokyo, Japan
1 shared publication Hirohisa Endo
Department of Infection Control and Prevention, University of Tokyo Hospital, Tokyo, Japan
1 shared publicationHirotoshi Matsui
Department of Geriatric Medicine University of Tokyo Hospital Bunkyo‐ku Tokyo 113‐8655 Japan
1 shared publicationHisako Yano
1 shared publication
Latest Publications
- Open Access
- 15 November 2001
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 33 (10) , 1756-1761
Diagnosis and Monitoring of Human Cytomegalovirus Diseases in Patients with Human Immunodeficiency Virus Infection by Use of a Real‐Time PCR Assay
We used a real-time PCR assay to measure human cytomegalovirus (HCMV) DNA load in whole blood and plasma of 70 patients who were infected with human immunodeficiency virus type 1. Break points of 3.0 × 103 copies/mL in whole blood and 1.0 × 103 copies/mL in plasma were well-correlated with the existence of definite HCMV disease (sensitivity, 93% and 86%; specificity, 89% and 85%; positive predictive value, 70% and 63%; and negative predictive value, 98% and 95%, respectively). In patients with + T lymphocytes, positive predictive values increased to 78% and 71%, respectively. The viral loads of all patients who received anti-HCMV therapy declined to ⩽ 2.0 × 102 copies/mL in parallel with the improvement of clinical symptoms. These findings show that the HCMV DNA load quantified with our method is a useful tool for diagnosis of HCMV diseases and for monitoring the disease activity in patients infected with HIV-1.
- 15 November 2001
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 33 (10) , 1756-1761
Open AccessDiagnosis and Monitoring of Human Cytomegalovirus Diseases in Patients with Human Immunodeficiency Virus Infection by Use of a Real‐Time PCR Assay
We used a real-time PCR assay to measure human cytomegalovirus (HCMV) DNA load in whole blood and plasma of 70 patients who were infected with human immunodeficiency virus type 1. Break points of 3.0 × 103 copies/mL in whole blood and 1.0 × 103 copies/mL in plasma were well-correlated with the existence of definite HCMV disease (sensitivity, 93% and 86%; specificity, 89% and 85%; positive predictive value, 70% and 63%; and negative predictive value, 98% and 95%, respectively). In patients with + T lymphocytes, positive predictive values increased to 78% and 71%, respectively. The viral loads of all patients who received anti-HCMV therapy declined to ⩽ 2.0 × 102 copies/mL in parallel with the improvement of clinical symptoms. These findings show that the HCMV DNA load quantified with our method is a useful tool for diagnosis of HCMV diseases and for monitoring the disease activity in patients infected with HIV-1.
- Open Access
- 1 September 2000
- Published by Wiley in Microbiology and Immunology
- Vol. 44 (9) , 749-754
Effect of Ions on Antibacterial Activity of Human Beta Defensin 2
Human beta defensin 2 (HBD‐2), the most recently discovered human defensin, has been considered to work as a host defense substance against microbial infection. Using Escherichia coli ATCC 25922, we investigated how some cations and anions influenced the antimicrobial activity of HBD‐2. This activity, measured in 10 mm phosphate buffer at a concentration of 20 μg/ml, reduced significantly in the presence of 100 and 150 mm sodium or potassium chloride. The reduction was not significantly different when the total amounts of sodium and potassium ions were equal. The kind and the valence of anions (chlorine and sulfate ions) did not affect the bactericidal activity as long as the concentrations of sodium ions were equal. Divalent ions (calcium and magnesium ions) added to 10 mm of Tris buffer significantly inactivated HBD‐2 at much lower concentrations (more than or equal to 0.01 mm and 0.05 mm, respectively) than the monovalent ions did. These findings suggest that HBD‐2 kills the bacteria through at least two phases, which are affected independently by either monovalent or divalent ions and unaffected by anions.
- 1 September 2000
- Published by Wiley in Microbiology and Immunology
- Vol. 44 (9) , 749-754
Open AccessEffect of Ions on Antibacterial Activity of Human Beta Defensin 2
Human beta defensin 2 (HBD‐2), the most recently discovered human defensin, has been considered to work as a host defense substance against microbial infection. Using Escherichia coli ATCC 25922, we investigated how some cations and anions influenced the antimicrobial activity of HBD‐2. This activity, measured in 10 mm phosphate buffer at a concentration of 20 μg/ml, reduced significantly in the presence of 100 and 150 mm sodium or potassium chloride. The reduction was not significantly different when the total amounts of sodium and potassium ions were equal. The kind and the valence of anions (chlorine and sulfate ions) did not affect the bactericidal activity as long as the concentrations of sodium ions were equal. Divalent ions (calcium and magnesium ions) added to 10 mm of Tris buffer significantly inactivated HBD‐2 at much lower concentrations (more than or equal to 0.01 mm and 0.05 mm, respectively) than the monovalent ions did. These findings suggest that HBD‐2 kills the bacteria through at least two phases, which are affected independently by either monovalent or divalent ions and unaffected by anions.
- 1 January 1998
- Published by The Japanese Association for Infectious Diseases in Kansenshogaku Zasshi
- Vol. 72 (11) , 1176-1181
Antimicrobial Effects of Electrolytic Products of Sodium Chloride-Co
We examined the in vitro bactericidal effects and efficacy on handwashing of water containing electrolytic products of sodium chloride (electrolytic water). The electrolytic water, whose pH and concentration of free residual chlorine were 6.7-6.9 and 20-22 ppm, respectively, showed equal reduction of both Staphylococcus aureus and Escherichia coli to dilution of commercially available sodium hypochlorite containing 60 ppm of free residual chlorine. This bactericidal effect was calculated to be due to hypochlorous acid, based on the pH and the amount of chlorine in solution. Handwashing with the electrolytic water reduced the numbers of S. aureus on hands by 1/10(2), while running water and 0.2% benzalkonium chloride with 80% ethanol gave a 1/10 and 1/10(5) reduction, respectively. We conclude that electrolytic water might be applicable for handwashing in place of running water.
- 1 January 1998
- Published by The Japanese Association for Infectious Diseases in Kansenshogaku Zasshi
- Vol. 72 (11) , 1176-1181
Antimicrobial Effects of Electrolytic Products of Sodium Chloride-Co
We examined the in vitro bactericidal effects and efficacy on handwashing of water containing electrolytic products of sodium chloride (electrolytic water). The electrolytic water, whose pH and concentration of free residual chlorine were 6.7-6.9 and 20-22 ppm, respectively, showed equal reduction of both Staphylococcus aureus and Escherichia coli to dilution of commercially available sodium hypochlorite containing 60 ppm of free residual chlorine. This bactericidal effect was calculated to be due to hypochlorous acid, based on the pH and the amount of chlorine in solution. Handwashing with the electrolytic water reduced the numbers of S. aureus on hands by 1/10(2), while running water and 0.2% benzalkonium chloride with 80% ethanol gave a 1/10 and 1/10(5) reduction, respectively. We conclude that electrolytic water might be applicable for handwashing in place of running water.